Grant Learmont, 40, was diagnosed with stage 4 prostate cancer after initially experiencing minor back and hip pain. The dad ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

The risk of developing prostate cancer almost doubles in men who skip out on one important thing. Roughly one in eight men ...

Preclinical work has shown KRAS inhibition can delay cancer onset and extend survival in mice with pancreatic intraepithelial neoplasia lesions.

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Examples include (i) “low” PSMA uptake in a slightly enlarged lymph node (s) in men with newly diagnosed or recurrent ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, ...

ANSWER: The D-dimer test looks for the breakdown of fibrin, which is a major protein that is involved in blood clotting. High ...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.